An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Conclude your understanding of lymphoma with an in-depth look at its signs and symptoms, from common indicators to subtle clues.

Speaker : Dr Suvir Singh

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

Explore how CDK4/6 inhibitors improve overall survival in HR+/HER2- advanced breast cancer patients with Dr. Anju Malhotra.

Speakers : Dr. Anju Malhotra

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

Explore advanced urothelial carcinoma treatment strategies with Dr. Nagender Sharma. Discover immunotherapy, targeted therapies, and personalized approaches in this expert-led oncology discussion.

Speakers : Dr Nagendra Sharma

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

Explore the hospitalization burden, healthcare impact, and resource demands in patients with relapsed or refractory acute lymphoblastic leukemia (ALL).

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

Learn about early relapse in B-cell ALL, including relapse rates within the first year, key risk factors, and the most common sites like bone marrow and CNS.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

Exploring novel therapies and redefining long-term survival outcomes in adult relapsed/refractory B-cell ALL through precision and immunotherapy.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

Explore optimal first-salvage therapies for adult R/R B-Cell ALL with high disease burden, advancing remission and personalized treatment.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD

xplore MRD-guided therapies in adult R/R B-ALL, with insights on CAR-T, blinatumomab, and personalized strategies for achieving long-term remission.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

Discover groundbreaking treatments offering new hope for adults with relapsed B-cell ALL. Explore the latest advances, therapies, and strategies transforming outcomes in this challenging leukemia.

Speakers : Dr Riyaz Ahmed ,Dr Isha Kaul ,Dr Nitin Gupta

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

Explore the unmet needs in ALK-positive NSCLC with Dr. Vamshi Krishna M as he discusses current challenges, treatment gaps, and future directions in lung cancer care.

Speakers : Dr. Vamsi Krishna M

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

Explore the revolutionary potential of Lorlatinib, a third-generation ALK-TKI, through the CROWN trial with Dr. Vamshi Krishna M.

Speakers : Dr. Vamsi Krishna M


Recommended News For You

According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.

What are the factors that cause oral mucositis to be severe after receiving radiation for head and neck cancer?

Minimally invasive prostate cancer treatment shows success in first patient

Chronic pain and poor sleep are troublesome bed partners.

Patients face high out-of-pocket costs after incident cancer diagnosis

FDA Expands Approval of Osimertinib in Lung Cancer

Best foot forward—chemo care should include podiatry, say researchers

Recommended Articles For You

From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma 

Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment 

Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training 

MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New drug combination shows good results in patients with HPV-negative head and neck cancer

2.

A new drug delivery system may help patients with a rare eye cancer

3.

C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

4.

What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care

5.

Prostate cancer death risk is higher in late teens and early 20s weight gain.

1.

Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options 

2.

Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression

3.

Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care

4.

Anemia in Older Adults: Causes, Clinical Impact, and Evidence-Based Management

5.

Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

3.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot